LEONHARDT VENTURES ANNOUNCES NEW PROVISIONAL PATENT APPLICATION TARGETING IL-1β AND PGE2 TO ACCELERATE ORTHODONTIC TOOTH MOVEMENT
FOR IMMEDIATE RELEASE LEONHARDT VENTURES ANNOUNCES NEW PROVISIONAL PATENT APPLICATION TARGETING IL-1β AND PGE2 TO ACCELERATE ORTHODONTIC TOOTH MOVEMENT Patent Intended for Exclusive License to OrthodontiCell, Inc. NEWPORT BEACH, CALIFORNIA — June 20, 2026 —...
Leonhardt Ventures LLC Celebrates 25th Anniversary of Launching First Aging Reversal Major Organ Regeneration Clinical Programs
Historic MyoCell™ Heart Regeneration Program Evolves Into BioLeonhardt™ and Lionheart Octopus™ Multi-Organ Regeneration Platform HUNTINGTON BEACH, Calif. — Leonhardt Ventures LLC is proud to celebrate the 25th anniversary of the launch of one of the world’s...
Leonhardt Ventures LLC Announces Provisional Patent Application for Bioelectric Stimulation of Bone to Increase Osteocalcin Expression for Brain, Sexual, Metabolic and Healthy Aging Benefits
HUNTINGTON BEACH, CA – June 4, 2026 – Leonhardt Ventures LLC announced today a new provisional patent application covering methods and systems for the use of targeted bioelectric stimulation of bone to increase expression and release of osteocalcin, a hormone...
Leonhardt Ventures Announces Provisional Patent Application for Bioelectric Controlled Expression of OSER1 for Healthspan and Longevity
Huntington Beach, California – June 4th, 2026 – Leonhardt Ventures LLC announced today that it has prepared a provisional patent application covering methods, systems, devices, and protocols for the bioelectric controlled expression of Oxidative Stress Responsive...
Leonhardt Ventures Provisional Patent Application for ArchStim™ Smart Expansion & Stabilization System
A New Approach to Improving Breathing, Expanding Narrow Arches, and Addressing a Root Cause of Crooked Teeth HUNTINGTON BEACH, Calif. — June 3rd, 2026 — Leonhardt Ventures LLC today announced preparation of a provisional patent application covering a...
Leonhardt Ventures Files Provisional Patent Application for Bioelectric Enhancement of Menin Expression in the Brain
Licensed to Lionheart Health for Development Through the Brain Band™ Platform Huntington Beach, California – June 1, 2026 – Leonhardt Ventures LLC announced today the filing of a provisional patent application covering methods and systems for the bioelectric...
LIONHEART HEALTH ANNOUNCES PAINSTIM™ PLATFORM FOR REGENERATIVE PAIN RELIEF
Combining Bioelectric Protein Expression™, Klotho Activation, and Precision Neuromodulation to Address Chronic Pain at Its Source HUNTINGTON BEACH, Calif., May 31, 2026 — Lionheart Health, Inc. today announced the launch of PainStim™, a next-generation regenerative...
Leonhardt Ventures and Lionheart Health Announce U.S. Patent Allowance for Bioelectric Control of Sirtuin (SIRT6) Longevity Proteins
Newport Beach, California — May 26, 2026 — Leonhardt Ventures LLC and Lionheart Health, Inc. today announced receipt of a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for pioneering patent claims covering the bioelectric control of...
Leonhardt Ventures LLC Surpasses Historic Milestone with Over 1 Million Patients Treated with Its Inventions and Technology Platforms
HUNTINGTON BEACH, Calif., May 23, 2026 — Leonhardt Ventures LLC announced today that technologies, inventions, and derivative product families associated with founder Howard J. Leonhardt and affiliated innovation programs have now contributed to the treatment of...
Lionheart Health Preparing to Begin Enrollment in Updated OUS Pilot Study for Next Gen ImplantStim™ – Bioelectric Dental Implant for Rapid Healing & Integration
Newport Beach, California – May 15, 2026 – Lionheart Health http://www.LionheartLongevity.com announced today that it is preparing to begin patient enrollment in a new outside-the-United States (OUS) pilot study evaluating the company’s updated ImplantStim™...